Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

H Liu, Z Hu, M Li, Y Yang, S Lu, X Rao - Journal of biomedical science, 2023 - Springer
Abstract Gram-positive (G+) bacterial infection is a great burden to both healthcare and
community medical resources. As a result of the increasing prevalence of multidrug-resistant …

Phage-encoded endolysins

F Abdelrahman, M Easwaran, OI Daramola, S Ragab… - Antibiotics, 2021 - mdpi.com
Due to the global emergence of antibiotic resistance, there has been an increase in
research surrounding endolysins as an alternative therapeutic. Endolysins are phage …

Potential for bacteriophage endolysins to supplement or replace antibiotics in food production and clinical care

MJ Love, D Bhandari, RCJ Dobson, C Billington - Antibiotics, 2018 - mdpi.com
There is growing concern about the emergence of bacterial strains showing resistance to all
classes of antibiotics commonly used in human medicine. Despite the broad range of …

Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy

H Oliveira, C São-José, J Azeredo - Viruses, 2018 - mdpi.com
Peptidoglycan degrading enzymes are of increasing interest as antibacterial agents,
especially against multi-drug resistant pathogens. Herein we present a review about the …

Phage lysins for fighting bacterial respiratory infections: a new generation of antimicrobials

R Vázquez, E García, P García - Frontiers in immunology, 2018 - frontiersin.org
Lower respiratory tract infections and tuberculosis are responsible for the death of about 4.5
million people each year and are the main causes of mortality in children under 5 years of …

[HTML][HTML] Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents

Ł Grabowski, K Łepek, M Stasiłojć… - Microbiological …, 2021 - Elsevier
Appearance of pathogenic bacteria resistant to most, if not all, known antibiotics is currently
one of the most significant medical problems. Therefore, development of novel antibacterial …

Advanced engineering of third-generation lysins and formulation strategies for clinical applications

V De Maesschalck, D Gutiérrez… - Critical reviews in …, 2020 - Taylor & Francis
One of the possible solutions for the current antibiotic resistance crisis may be found in
(often bacteriophage-derived) peptidoglycan hydrolases. The first clinical trials of these …

Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases

AS Bolocan, A Upadrasta, PH de Almeida Bettio… - Viruses, 2019 - mdpi.com
Bacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial
agents to fight against antibiotic-resistant bacteria associated with human infections …

An enterococcal phage-derived enzyme suppresses graft-versus-host disease

K Fujimoto, T Hayashi, M Yamamoto, N Sato… - Nature, 2024 - nature.com
Abstract Changes in the gut microbiome have pivotal roles in the pathogenesis of acute graft-
versus-host disease (aGVHD) after allogenic haematopoietic cell transplantation (allo …

The clinical path to deliver encapsulated phages and lysins

AM Pinto, MD Silva, LM Pastrana… - FEMS Microbiology …, 2021 - academic.oup.com
The global emergence of multidrug-resistant pathogens is shaping the current dogma
regarding the use of antibiotherapy. Many bacteria have evolved to become resistant to …